What Happened?
, -based Turn Biotechnologies Appointed Richard Peterson as Chief Financial Officer
About the Company
Turn Biotechnologies develops mRNA medicines that induce the body to heal itself by instructing specific cells to fight disease or repair damaged tissue. We are focused on reprogramming the epigenome – a network of chemical compounds and proteins that control cell functions by influencing which genes are active – to restore capabilities that are often lost with age.
About the Person
Richard Peterson is Chief Financial Officer at Turn Biotechnologies. Previously, Richard held various senior HR leadership roles in the industry.
Info Source
News
Short Profile